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THE LYMPHATIC SYSTEM CONSISTS of a network of vessels, nodes, and accessory organs that play an essential role in the body's balance of interstitial fluid volume by draining lymph from the interstitial space back to the bloodstream. This system is vital for maintenance of oncotic pressure gradients (17, 37, 50a) , immune cell trafficking (38, 46, 55) , and lipid transport (16, 29, 40) . After uptake by the initial lymphatics, lymph is driven through the collecting lymphatics by a combination of intrinsic and extrinsic factors. Intrinsic factors describe the active lymphatic pump, in which discrete pumping units, known as lymphangions, contract to generate a pressure that propels fluid downstream back to the circulation (49, 53, 71) . Extrinsic factors are composed of other mechanisms that assist to propel lymphatic flow in addition to the intrinsic lymphatic contractions. These include lymph formation, pulsations in the circulatory system, respiration, and muscle pumps during musculoskeletal movement (11, 23) . A combination of both intrinsic and extrinsic factors are essential to propel fluid against both an adverse pressure gradient from the interstitium and unfavorable hydrostatic pressure gradients (22, 76) . When lymphatic function is impaired or inhibited, a number of pathologies may develop, most notably lymphedema, which is characterized by edema, lipid accumulation, and gross tissue remodeling in the affected limb (44, 51, 54, 60, 63) . Currently, no cure exists for lymphedema, our understanding of the factors that contribute to disease progression is incomplete, and our ability to diagnose lymphatic vascular disease is severely limited. Considering the benefits to patient care associated with routine measurements of blood pressure, the ability to noninvasively monitor lymphatic pumping pressure could be a significant step toward clinical solutions for those suffering from lymphatic diseases. The first step toward development of such an approach is to gauge the effectiveness of measuring lymphatic pumping pressure in animal models that have undergone perturbations in lymphatic function. These animal models would provide essential insight into the physiological factors that contribute to the measure of lymphatic pumping pressure.
A major hurdle to the study of lymphatic health is the paucity of noninvasive in vivo imaging diagnostics that are capable of quantifying the effectiveness of lymphatic transport (57) . Although numerous techniques have been used to visualize lymphatic drainage, including lymphoscintigraphy, MRI, and PET, they have yet to be utilized routinely as a research tool for functional lymphatic imaging due to their prohibitive cost and/or lack of appropriate sensitivity (4, 42, 45, 62) . With the growing interest in the study of the lymphatic system, near-infrared (NIR) imaging has emerged as one of the more promising imaging modalities due to its ideal combination of spatial and temporal resolution, allowing for dynamic imaging of initial and collecting lymphatics in real time (62, 67) . NIR imaging provides excellent spatial resolution for superficial lymphatics because NIR excitation light resides in wavelength ranges (Ͼ750 nm) that are minimally scattered and absorbed by biological tissues (3, 18) . When these resolution capabilities are combined with the video frame rates available with EMCCDs, the technique is optimal for dynamic imaging of collecting lymphatic function (73) . NIR imaging with the FDA-approved fluorophore, indocyanine green (ICG), has gained significant traction in assessment of lymphatic architecture and function in both health and disease, primarily due to its low cost and previous Food and Drug Administration approval (33, 34, 56, 57) . Using this technique, we inject a concentration of ICG intradermally where it is taken up by the lymphatics. It is then excited at noninfrared (NIR) wavelengths by a laser diode and imaged using a charge-coupled device (CCD) or electromagnetic (EM)-CCD camera with appropriate optics and filters. By utilizing this modality, various quantitative metrics have been developed to characterize lymphatic function, including packet velocity, packet frequency, and transport time (33, 34, 52, 57, 62, (67) (68) (69) (70) 73) . These methodologies have been used to show differences in lymphatic function and architecture in patients with lymphedema, as well as evaluate acute response to manual lymphatic drainage and compression treatment. While research in lymphatic imaging is making great strides toward the development of evaluations of lymphatic health, there are limited diagnostic technologies that can effectively monitor the loss of lymphatic function.
Currently, it is unknown how impaired intrinsic pumping capabilities of the lymphatics contribute to the progression of disease. Histological analysis of lymphatic vessels in humans and various animal models affected by lymphatic dysfunction have suggested alterations in lymphatic vessel smooth muscle coverage (39, 43) . However, it is unclear how these changes directly impact lymphatic pumping and the role that this plays in disease progression. It is possible that early changes in lymphatic pumping capacity are a sign of disease risk or onset. These changes in pump function could potentially be quantified and then be used to inform patients of the state of their lymphatic health (48, 68, 70) . While pumping pressure of lymphangions has been measured in situ (5, 28) , the ability to obtain a minimally invasive measurement of the pumping capacity of the lymphatic network in vivo would be an invaluable tool, both as a diagnostic and for longitudinal studies on disease progression. Excitingly, two important developments have been made recently in this regard. By using an occlusion cuff to stop lymphatic flow, deflating the cuff, and then measuring the pressure at which flow is restored by visualizing lymphatic transport with either lymphoscintigraphy (48) or NIR imaging (68, 70) , researchers were able to report significant differences in pumping pressure between normal patients and those with advanced lymphedema. However, the results of the measurements were subject to a high degree of variability across each patient group, as well as a high degree of variability when comparing one imaging modality to the other. This could be due in part to the large-pressure decrements (10 mmHg) used during deflation of the pressure cuff in the previously described manual and open-loop approaches (48, 68, 70) . Given these limitations, this technique has yet to be widely adopted as a diagnostic tool. We believe that improvement upon these resolution capabilities will increase the sensitivity of the measurement, allowing us to further explore its suitability for early-stage detection of lymphatic dysfunction. Additionally, by adapting it for application in rodent animal models, we will allow for its wide use as a research tool in the quantitative study of lymphatic function in health and disease.
The purpose of this study was to develop a novel research platform to determine the effective lymphatic pumping pressure (P eff ), packet restoration pressure, and emptying rate in rodents with minimal invasiveness by incorporating a closedloop feedback system to control the occlusion pressure applied to the lymphatic vessel while simultaneously recording lymph transport with NIR imaging. We established the technique with the rat tail model, which was chosen because of the symmetry and anatomical consistency of the two collecting lymphatic vessels that drain along the sides of the tail. The rodent tail is one of the most widely used animal models in lymphatic research and has provided remarkable insight into basic lymphatic physiology (6, 36, 64, 73) , lymphangiogenesis (7, 12, 26, 74) , and lymphedema pathology (2, 60, 65, 75) . Despite our methodology being optimized for use in the rodent tail, we also demonstrate that the same technique can be employed to obtain functional data from the rat forelimb. To validate the sensitivity of our measurements to changes in lymphatic function, we used a dermal nitric oxide (NO) donor ointment. NO has been shown to be a regulator of lymphatic function in several pathophysiological or inflammatory conditions (1, 31, 35, 39, 58) . Additionally, NO has been implicated in the inhibition of the intrinsic contractile capabilities of isolated lymphatic vessels (20, 47) and the slowing of lymph transport in vivo (61, 73) . On the basis of these studies, we expected the application of dermal NO donor ointment to reduce the observed P eff and emptying rate values obtained using our system and, thus, show that our method is sufficiently sensitive to detect slight alterations of lymphatic function in vivo in a minimally invasive fashion.
METHODS

Pressure cuff controller.
A closed-loop pressure cuff system ( Fig. 1 ) was designed using a commercially available pressure cuff (Kent Scientific, Torrington, CT). The pressure cuff was attached to a 5-ml BD luer-lock syringe via plastic tubing (1/16Љ ID, 1/8Љ OD) and to a precalibrated pressure transducer (Honeywell Sensing and Control, Morristown, NJ) via a plastic barbed T-fitting and additional plastic tubing (1/8Љ ID, 1/4Љ OD). The pressure transducer was connected to a data acquisition device [National Instruments (NI), Austin, TX], and pressure values were read in LabView. The pressure transducer was factory calibrated, but calibration was confirmed via a water column. A customized LabView virtual instrument (VI) (NI, LabView 2012 32-bit) was used to control the serial command output to the syringe pump (Harvard Apparatus PHD 2000 Infusion/Withdraw 70 -2001). Pressure transducer readings were sampled at 10 Hz and passed through a 5-point moving average filter. The difference between the desired pressure and the sampled pressure was used to control the flow rates on the syringe pump to subsequently inflate or deflate the pressure cuff. This was accomplished using simple on-off control. If the absolute pressure difference between the desired and sampled pressures was greater than 7 mmHg, then a "high" infuse or refill flow rate of 1.00 ml/min was sent to the syringe pump. If the absolute pressure difference was less than 7 mmHg, then a "low" infuse or refill flow rate of 0.25 ml/min was sent to the syringe pump. This allowed for a quicker response when the difference between the desired and measured pressure was large and a slower, finer response when it was small which minimized overshoot. These prescribed flow rates were used to modulate displacement of the syringe, thereby altering the volume and pressure of air inside the closed-tube system, and thus the pressure applied through the occlusion cuff to the tail or forelimb.
Aided by the real-time feedback of the pressure transducer, the closed-loop system allowed for steady-state tracking of the desired pressure with an overall root mean squared steady-state error of 0.48 mmHg, excluding the initial ramp-up to 80 mmHg (Fig. 2) . Fluctua-tions at steady state were mostly due to noise in the pressure transducer measurements. The rise and fall times were fast enough for accomplishing the purposes of this experiment, while avoiding significant undesirable overshoot. Overdamping of the system was acceptable since the slight increase in time to reach a desired pressure value would not significantly affect the total duration of the experiment. Our LabView control algorithm and VI are available on request or can be downloaded on our laboratory's website: http://llbb. gatech.edu.
Imaging system. The NIR imaging system was set-up as described previously (73) . A diode driver and temperature control box powered a 1-W 808-nm laser diode (Thorlabs, Newton, NJ), which provided excitation light. To disperse the laser over a larger area of ϳ75 cm 2 with less than 1.9 mW/cm 2 , a 20-degree beam diffuser (Thorlabs, Newton, NJ) was fixed in front of the diode. An Infinity K2/SC video ϫ2.15 magnification microscope lens (Edmund Optics, Barrington, NJ) and a bandpass filter (CW: 840 nm, FWHM: 15 nm, Omega Optical, Brattleboro, VT) were attached to a PIXIS 1024B backilluminated CCD camera (Princeton Instruments, Trenton, NJ) to capture fluorescence emission centered at 840 nm. These wavelengths were chosen on the basis of previous work that showed that ICG undergoes a spectral shift when it binds to albumin (73) . The camera was connected to the same computer as used for the pressure cuff system, where the images were acquired by an additional custom LabView VI.
In vivo data collection. A standardized procedure was carried out on 9-wk-old male Sprague-Dawley (Charles River, Wilmington, MA) rats. To minimize light scattering, a depilatory lotion was used to remove hair in the region of interest on the tail or forelimb 1 day prior to experimentation. Rats were anesthetized with an intramuscular injection of diazepam (2.5 mg/kg) followed by a cocktail of fentanyl (0.12 mg/kg) and droperidol (6 mg/kg). After waiting for ϳ10 min for the anesthetics to take effect, the rat was positioned under the camera. Animals in the treatment group received a topical application of 500 mg glyceryl trinitrate ointment (GTNO; 0.2% wt/wt, Rectogesic, Care Pharmaceuticals) applied to the entirety of the tail. To confirm that GTNO ointment was not drastically altering lymph formation and dye uptake at the injection site on the tail, an additional group of treatment animals had GTNO ointment applied only to areas of the tail 3 cm downstream of the injection site. Control animals received no GTNO ointment.
The pressure cuff was calibrated by removing and then reattaching the tubing connected to the syringe to ensure that the steady state pressure was zero. The proximal edge pressure cuff (0.7 cm ID) was placed 12 cm or 4 cm from the tip of the tail at which point the inner diameter of the cuff was uniformly touching the tail without applying any pressure, as verified by transducer readings. For a subset of rats, a larger pressure cuff (1 cm ID) was fitted on the outstretched forelimb, past the elbow joint, with the proximal edge of the cuff 4 cm from the phalanges. Also, the cuff was positioned on the tail or forelimb in the same rotational orientation for each rat to compensate for any nonuniformity in pressure application by the elastic bladder during inflation. The rat was positioned so that the field of view was proximal to the cuff, including only the edge of the cuff. A mixture of 30 l of ICG/albumin solution (150 g/ml ICG; Acros Organics, Geel, Belgium) and 60 g/ml BSA (MP Biomedicals, Auckland, New Zealand) was dissolved in deionized water and injected intradermally at the tip of the tail, as described previously (73), or in the footpad of the forelimb.
Image acquisition began just prior to intradermal injection of the dye. Once steady-state fluorescence was established, more than 3 min after injection, a predetermined sequence of pressure cuff applications was administered to the tail. Specifically, the pressure was increased to 80 mmHg over a period of ϳ65 s and held at this value for 10 min to allow for the proximal vessel to completely empty its contents. This pressure was chosen for lymph flow occlusion because 80 mmHg is close to the diastolic blood pressure of a rat and well below the mean arterial pressure, so blood supply was not occluded during the exper- Fig. 1 . An automated, integrated, feedback-controlled, lymphatic pumping pressure and imaging system with user interfaces serves as a powerful tool set for lymphatic physiology. A schematic of the pressure cuff system, including labeled depictions of its various components, is shown. Top right: sample near-infrared image of a rat tail with an example region of interest (ROI) identified. The pressure cuff can be seen at the right of the image. Although two lymphatic vessels are visualized along the sides of the tail, the excitation source was focused on the lower vessel, which was used for quantification. Bottom right: bright-field image of the pressure cuff placed on the rat tail, as well as the indocyanine green (ICG) injection site. Fig. 2 . Feedback-controlled pressure curves are applied to the tail with sufficient precision and speed. The pressure curve used to apply pressure during each experiment is shown. The exploded image shows the close tracking of the filtered actual pressure to the desired pressure. Root mean squared error (RMSE) for the entire pressure curve (disregarding the initial ramp up to 80 mmHg) for this curve is 1.821 mmHg. Steady RMSE during the 10 min at 80 mmHg is 0.477 mmHg. The actual pressure data were filtered throughout the experiment using a 5-rank mean filter. The reported mean squared errors are based on this filtered data. iment (10) . After 10 min at 80 mmHg, the pressure was decreased to 55 mmHg over a period of ϳ25 s. The pressure was then decreased in decrements of 2.5 mmHg and held at each pressure step for 60 s, until the pressure value was zero, where it remained for 3 min before the program was terminated. The pressure cuff controller took less than 15 s to reach each new pressure decrement. This standardized pressure curve was used for all experiments (Fig. 2) .
Images of the tail or forelimb were captured by the NIR imaging system throughout the experiment at a frame rate of 1 fps with a camera exposure time of 50 ms. This frame rate has been shown to provide sufficient temporal resolutions for dynamic imaging of lymphatics (73) . After the first frame was captured, the system paused to allow the user to select a region of interest (ROI), which was positioned just proximal to the pressure cuff, over the fluorescent vessel. The mean intensity within the ROI was calculated in real time and was displayed on a plot throughout the procedure (Fig. 3) . The ROI selected for use in the data analysis was always positioned over the left vessel of the tail (Fig. 4) or a lymphatic vessel residing on the front of the left forelimb. This was done both for the sake of consistency and to optimize the optics for achieving the best signal on a single vessel. The intensity plots obtained were consistent in form between all experiments. While flow was occluded at 80 mmHg, a gradual emptying of fluorescence within the proximal vessel was observed. Fluorescence was not restored until the pressure applied to the cuff was lowered and was no longer sufficient to occlude flow within the vessel (Fig. 4) .
To confirm that GTNO did not have significant effects on the arterial blood pressure (ABP), we measured ABP in four animals preand 20 min post-GTNO application. ABP was measured using a noninvasive blood pressure monitor NIBP-8 (Columbus Instruments, Columbus, OH). All animal procedures were performed in accordance with the Georgia Institute of Technology Internal Animal Care and Use Committee and complied with National Institutes of Health Guide for Care and Use of Laboratory Animals.
Functional image processing. Three primary measurements were taken from each intensity plot and pressure curve combination using customized data analysis algorithms written in MATLAB. The first was P eff, which was calculated using two points: the minimum intensity value before flow restoration and the maximum intensity value after flow restoration. The average of these two values was the intensity threshold for flow restoration. The pressure at the time where the intensity rose to equal the intensity threshold was P eff (Fig. 3) . The second parameter determined was the "packet restoration pressure". NIR imaging of lymphatic uptake produces discrete packets of fluorescence that travel through the vessel as a result of the intrinsic contractility of the lymphatic vessels working in coordination with lymphatic valves. The frequency of these packets has previously been reported as a measurement of lymphatic function (73) . To determine the pressure at which packet flow was restored in the lymphatic vessel, a fast Fourier transform was used to calculate the power spectral density (PSD) of the intensity signal in the frequency range of 0.06-2 Hz prior to flow occlusion (before 80 mmHg) and after complete flow restoration (at 0 mmHg). Since packet frequency can be somewhat variable, even in nonoccluded vessels, the PSD was used to calculate the magnitude of the spectral content within this frequency range to provide a measure of contractile activity. The point at which this value recovered to 50% of its nonoccluded value was indicative of the restoration of packet flow. The packet restoration metric was used to identify the pressure when packets were evident that rivaled those seen during uninhibited flow (Fig. 3) . The third parameter was the average "emptying rate" of the vessel during flow occlusion, the average rate of fluorescence intensity decrease as the proximal vessel emptied during the period when the pressure was raised and held at 80 mmHg (ER; Fig. 3 ). To calculate the average emptying rate of the vessel, two time points were used: the time of maximal fluorescence at the beginning of flow occlusion and the time at which the intensity fell within 5% of the minimal steady state value during flow occlusion. The average emptying rate was then calculated as the difference Fig. 3 . Top: overlaid pressure and intensity plots demonstrate the calculation of the effective pumping pressure (Peff) and the emptying rate (ER). Typical packet flow that is present before the beginning of flow occlusion (bottom left) is recovered after occlusion (bottom right). To quantify the point at which packet flow was restored, the time at which the magnitude of the power spectral density function recovered to a specified value was calculated as described in the METHODS section.
in intensity over the difference in time between the two points. The values for P eff, packet restoration pressure, and emptying rate were averaged for the treatment and control groups and checked for statistical significance using a two-tailed unpaired Student's t-test.
RESULTS
Nitric oxide, via application of the GTNO ointment, significantly reduced P eff of the lymphatics in vivo from 34.8 mmHg to 18.5 mmHg, as determined by the functional NIR imaging system (P Ͻ 0.05) (Fig. 5) . Additionally, GTNO significantly reduced the average packet restoration pressure from 40.3 mmHg to 18.4 mmHg (P Ͻ 0.01). There was no statistical difference between the two different metrics of lymphatic pumping pressure (P eff and packet restoration pressure) for either control or GTNO-treated animals. GTNO application also caused a significant decrease in the emptying rate of fluorescence from the proximal vessel of the cuff after occlusion: from 6.15 IU/s to 2.19 IU/s (P Ͻ 0.05) (Fig. 6) . To determine the extent that the decreases in lymphatic pump function might have been caused by changes in lymph formation due to the effects of GTNO on blood pressure and/or capillary permeability, rather than due to the direct action of NO on lymphatics, GTNO application was restricted to areas 3 cm downstream of the injection site in a subset of rats. No differences were observed in P eff , packet restoration pressure, or emptying rate between rats with GTNO applied to the whole tail and those with the altered application protocol. Because no statistical difference was observed between these two treatment groups, they were grouped together in the comparison between GTNO and control (Figs. 5 and 6 ). To determine whether dermal NO application may have altered arterial blood pressure in the tail, blood pressure in a subset of rats (n ϭ 4) was measured before and 20 min after GTNO application. No statistical differences were observed in either systolic or diastolic arterial blood as a result of GTNO application.
To investigate the extent to which pressure cuff location affected our measurements, we positioned the proximal edge of the cuff and the imaging frame 4 cm from the tip of the tail. When functional measurements were taken at 4 cm, the P eff decreased to 15.2 mmHg from 34.8 mmHg (P Ͻ 0.01) in the control animals, which were measured at 12 cm from the tip of the tail (Fig. 7) . A similar trend was observed in the packet Fig. 4 . Top: representative intensity plot. The intensity spike at around 500 s is caused by the inflation of the pressure cuff to 80 mmHg pushing ICG dye into the ROI. While the pressure is held at 80 mmHg, the intensity within the ROI drops as the vessel is cleared of dye. As the pressure cuff is deflated using the control algorithm, the intensity within the ROI rises, indicating the beginning of flow restoration. Eventually, flow is completely restored within the vessel, and intensity plots exhibit typical packet flow. restoration pressure, which decreased to 11.6 mmHg from 40.3 mmHg (P Ͻ 0.05) (Fig. 7) . The average emptying rate obtained 4 cm from the tip of the tail was 6.60 IU/s, which was not statistically different from values obtained at 12 cm.
To demonstrate the feasibility of our method to be used on other anatomical locations more relevant to human pathologies we measured P eff , packet restoration pressure, and emptying rate on the forelimb of rats. Interestingly, when the cuff was placed on the left forelimb 4 cm from the phalanges, the measured P eff and packet restoration pressure values of 14.9 mmHg and 14.7 mmHg were not significantly different from the values obtained from measurements taken 4 cm from the tip of the tail but were 2 or 3 times less than the values collected at 12 cm on the tail (P Ͻ 0.01 and P Ͻ 0.05) (Fig. 7) . The average emptying rate of vessels on the forelimb was found to be 2.08 IU/s.
DISCUSSION
The ability to monitor pressure and hemodynamics in the blood circulation has been crucial for both assessing vascular health in a clinical setting and for probing the molecular mechanisms that regulate vascular biology in a laboratory setting. Development of technologies that enable similar measurements in the lymphatic vasculature in a noninvasive or minimally invasive fashion, such as those reported here, have the potential to make a substantial impact on the future of lymphatic research and patient care. Although the general approach of using an occlusion cuff to stop lymphatic flow as a means of determining the pumping pressure was pioneered previously in humans (48, 68, 70) , there are some substantial differences in the presented approach that improve the accuracy of the technique as a laboratory research tool. First, by using an automated, computer-controlled, closed-loop feedback system to generate the desired pressure curves, greater precision and sensitivity were achieved than with previous manually controlled, open-loop feed-forward systems (48, 68, 70) . Additionally, by combining this system with our previously optimized experimental functional lymphatic imaging platform (73) , improved spatial and temporal resolutions were achieved over lymphoscintigraphy (4, 42, 48, 62) .
Applying these techniques to the study of rodent lymphatic vessels has opened the door for future in vivo, noninvasive, studies on the regulation of lymphatic pumping and pump regeneration. The simple geometry and anatomy of the lymphatic vessels in the rodent tail make this an ideal location to measure P eff . Also, the rodent tail is one of the most developed animal models of lymphedema (2, 50, 60, 65, 75) , to which the addition of this toolset could provide remarkable insight into lymphedema progression and pathology. By artificially elevating the external pressure applied to the exterior of the vessel using the pressure cuff, we are able to determine the maximal external pressure that the lymphatic vessel is able to overcome, P eff . This pressure is much higher than previous measurements of systolic pressures in rats (5, 28) and is higher than the maximum pressure that can be overcome in isolated collecting lymphatic vessels that are exposed to an elevated output pressure (13) . However, in these previous experiments the pressure applied externally to the vessel is close to zero, and Fig. 5 . Dermally applied nitric oxide significantly reduced both the Peff and packet restoration pressure of the lymphatics (*P Ͻ 0.05 and **P Ͻ 0.01). The treatment group received 500 mg GTNO ointment applied to the tail (n ϭ 12). The control group received no GTNO ointment (n ϭ 5). Error bars represent means Ϯ SE. Fig. 6 . Dermally applied nitric oxide significantly decreased the average rate of emptying of the lymphatic vessel (*P Ͻ 0.05). The treatment group received 500 mg GTNO applied to the tail (n ϭ 12). The control group received no GTNO ointment (n ϭ 5). Error bars represent means Ϯ SE. Fig. 7 . When measurements were taken at 4 cm (n ϭ 3) from the tip of the tail vs. 12 cm (n ϭ 5), a significant decline in the Peff and packet restoration pressure was observed (**P Ͻ 0.01 and *P Ͻ 0.05). Peff and packet restoration pressure values obtained on the forelimb (n ϭ 5), 4 cm from the phalanges, were not significantly different from those obtained 4 cm from the tip of the tail. Values of Peff and packet restoration pressure on the forelimb were significantly different from those obtained at 12 cm from the tip of the tail (**P Ͻ 0.01 and *P Ͻ 0.05). Forelimb measurements exhibit very little difference in variability from measurements taken on the tail. Error bars represent means Ϯ SE.
thus, the average of the applied pressures at the inlet and outlet of the vessel equals the transmural pressure. To our knowledge, there are no measurements of systolic pumping pressure of an isolated lymphatic vessel that is under an elevated external pressure. Additionally, the injection itself, while only 30 l, could also elevate the contribution of the extrinsic factors to our pressure measurement.
GTNO was used to validate the sensitivity of the P eff and emptying rate measurements to physiological changes in lymphatic function because of its known inhibitory effects on lymphatic contractility. NO has been shown to decrease the intrinsic contraction of collecting vessels ex vivo (24, 47) , as well as decrease lymphatic transport in vivo (61, 73) . In fact, it is becoming apparent that NO is a primary mechanism used by lymphatics to regulate flow. Specifically, immune cells have been shown to release NO as a mechanism for manipulating lymphatic flow as part of a local immune modulatory response to inflammation (9, 25, 38, 41) . Also, transient changes in wall shear stress (WSS) on lymphatics lead to NO release as a means of either promoting vasodilation and reducing vascular resistance to flow during sustained WSS or possibly transiently increasing the vessel diameter as a regulatory mechanism for lymphatic pumping (8, 9, 24) . On the basis of the plethora of previous works that have demonstrated the effects of NO on lymphatic vessels, the use of a dermally applied NO donor provides an excellent pharmacological tool for modulating lymphatic function noninvasively.
In this study, we have demonstrated that our measurements of P eff and emptying rate are sensitive to perturbations in lymphatic function caused by NO. Specifically, we showed that the P eff was cut in half when GTNO was applied to the surface of the tails. This decrease in P eff shows that the lymphatics are less able to overcome flow occlusion with increased levels of NO and are, thus, less effective at moving fluid up the externally applied adverse pressure gradients. It is important to note that we do not propose that P eff is the actual systolic pressure of the lymphangions in the collecting vessel, but rather is a measure of the maximal externally applied pressure that can be overcome by the contributions of intrinsic and extrinsic factors that drive lymph flow. Since NO could have effects on extrinsic factors, it was important to determine whether the decline in P eff and emptying rate was primarily due to the loss in lymphatic contraction or a secondary result due to changes in the local Starling forces caused by lymph formation. NO could be affecting vascular permeability and, thus, lymph formation in two different ways. The first is that NO could increase vascular permeability and fluid extraversion into the interstitium (19, 66) , increasing lymph formation and subsequently driving lymph flow. The second is that given the potential of NO to lower capillary blood pressure, it is possible that GTNO could also decrease lymph formation, and thus, there would be less of a driving force of fluid upstream (32, 59 ). This appears unlikely because applying the occlusion cuff for 10 min at 80 mmHg likely blocks venous return. This would increase venous pressure and cause an increase in interstitial fluid buildup regardless of NO's effects on capillary permeability. In both of these scenarios, the conditions for lymph formation are high and, thus, should, in turn, correspond to increases in the extrinsic mechanisms responsible for lymph flow. However, we showed that P eff and packet restoration pressure were halved in the presence of GTNO. Also, application of GTNO away from the injection site, but still on the tail surface above the vessels at the measurement location, had the same effect on our metrics of lymphatic pump function as when applied to the entire tail. Therefore, the most likely explanation is that the decreases in P eff , packet restoration pressure, and emptying rate are due to the NO-induced loss of intrinsic lymphatic contractility, not a secondary result due to changes in lymph formation upstream.
We calculated the emptying rate to quantify the average rate of dye removal, a metric that is reflective of lymph flow (assuming that the solute flux follows the convection of the fluid). By occluding lymph flow distal to the imaging site, we were able to isolate the effects of intrinsic pumping from the effects of upstream lymph formation. It is reasonable to assume that the emptying rate captures an overall metric of lymphatic transport driven by intrinsic pumping effects of the downstream lymphatic chain (and perhaps the effects of nearby arterial pulsations). Since vessel filling is being occluded upstream of the imaging location by the pressure cuff, fluorescent dye must be transported out of the imaging location by intrinsic contractility of the lymphatic vessels. This metric, thus, decouples the effects of lymph formation upstream as a driver for lymphatic transport. In effect, emptying rate characterizes the downstream (proximal to the cuff) lymphatics' ability to transport fluid, whereas P eff characterizes the upstream (distal to the cuff) lymphatics. Utilizing these two metrics, we are able to characterize the effects of two separate segments of a single lymphatic vessel in the transport of fluid. GTNO significantly lowered the average emptying rate of the collecting vessels on the tail by nearly three-fold. This result follows a similar pattern to two previous studies, which showed that lymph transport is substantially decreased in the presence of GTNO (61, 73) . When the two metrics used in this study (P eff and average emptying rate) are examined in conjunction with two previous studies, it becomes clear that the pumping pressure measurement system provides a suitable platform for quantifying lymphatic function and potentially detecting dysfunction. Because the technique is minimally invasive, it allows for one to take multiple measurements of P eff and emptying rate during the course of longitudinal studies, in which it is hypothesized that there is a functional decline in lymphatic pumping capacity during disease progression (44, 51, 54, 60, 63) .
To examine the effects of lymphangion chain length on P eff , we varied the location of the cuff in relation to the tip of the tail. P eff measurements taken 4 cm from the tip of the tail were 2 to 3 times less than those obtained at 12 cm, whereas the emptying rate remained constant. The differences in P eff but not emptying rate with varying measurement locations are consistent with our understanding of the measurements. P eff captures the effects of the lymphatics distal to the pressure cuff to transport fluid. It stands to reason that as the number of lymphangions along a lymphatic vessel decrease, then the overall ability of the vessel to overcome an externally applied pressure gradient will also decrease. Emptying rate isolates the effects of the lymphatic vessels at the imaging location proximal to the pressure cuff to clear their remaining luminal contents. Previous in vivo measurements have suggested that lymph removal from a vessel is primarily due to the pumping activity of that vessel segment (14) . Since the number of lymphangions contributing to the measurement of emptying rate remains relatively constant regardless of cuff location, it is expected that emptying rate would not change at different locations within the tail. It is, however, unclear why emptying rate is lower in the forelimb than the two locations in the tail. This could be due to the presence of hydrostatic forces in the limb that are absent in the tail or differences in nodal resistance from the draining lymph node.
The observed effects of vessel chain length are consistent with recent studies that showed, via a lumped parameter modeling approach, chains of lymphangions in series could overcome larger adverse pressure gradients to drive fluid flow (30) , making it apparent that the number of lymphangions along a length of collecting vessel plays a fundamental role in the transport of lymph. When the lymphatic valves and lymphangions are functioning properly, as one would expect, each additional lymphangion increases the pumping capacity of the vessel chain. In humans, lymphatic vessels, long chains of lymphangions and valves, must contract to drain fluid from the distal portions of the limb. Although the rodent tail has no human analog, we believe that it provides an excellent research model for investigations relating functional metrics of lymph transport to vessel chain length. Thus, in some sense, when utilizing rodent animal models of lymphatic physiology, the tail is one of the more "physiological" locations to capture certain aspects of lymphatic physiology, since it is the only appendage in which lymph must be transported a considerable distance. Previous studies in humans showed a large variability in the obtained pumping pressure values (48, 68, 70) . This could be due to placing the cuff at slightly different distances from the terminal end of the lymphatic being measured. In contrast, rodent tail and limb lengths are highly consistent between similarly aged animals and breeds, which could have decreased the variability of our measurements presented in this study. Interestingly, in a previous study, men, who have longer limb lengths than women on average, exhibited higher observed pumping pressure (70) . It stands to reason that this difference could very well be due to differences in the measurement location along a lymphatic vessel chain, such as those demonstrated here.
Although the rodent tail does appear to have many advantages as a research tool, there is some concern that the low amount of variability we observed in our measurements is not due to the implemented feedback control of the pressure application, but rather is dependent on the unique anatomy of the tail and would not be as effective at other anatomical locations. This is of particular concern when evaluating the potential for this methodology to be used as a clinical tool. We used the forelimb to investigate other regions on the rat that could be used as a suitable measurement location. The animalto-animal variability of P eff values obtained on the forelimb was not significantly different from those obtained on the tail. This demonstrates that our methodology could be easily adapted for use in other animal models in which functional pump measurements are of interest. Interestingly, it appears that the measure of P eff is far more dependent on the length of the lymphatic vessel chain being measured as opposed to the anatomical location of measurement, whereas the emptying rate metric appears to vary with anatomical location. P eff values taken on the forelimb, 4 cm from the phalanges, were not significantly different from those obtained 4 cm from the tip of the tail. This result further demonstrates the importance of vessel chain length in the transport of lymph.
Throughout the experimental process, consistency was maintained for as many variables as possible. However, there are some limitations of the technique that are worth mentioning. First, the physiological effects of anesthesia on the measured P eff are unknown. This could be problematic in studies where it is suspected that the anesthesia itself might mask hypothesized losses in lymphatic pumping. Second, the application of the occlusion cuff at 80 mmHg for 10 min likely causes a buildup of interstitial fluid by blocking venous return. This would tend to give elevated measures of P eff over baseline values. However, the technique itself, while not providing a direct measurement of baseline systolic lymphatic pressure, is indicative of lymphatic pump function and provides, in our opinion, one of the most quantitative noninvasive measures of total lymphatic pumping capacity available. Third, we and others have reported effects of ICG on lymphatic pump function (21, 72) . On the basis of our most recent work, the negative effects of ICG appear primarily upon repeat injections and are reversible if enough time occurs between each injection (around 4 wk). Since multiple injections were not given in this study, this does not appear to be problematic. However, future work should focus on determining the effects of dye selection on the measurement of P eff . Lastly, there is some uncertainty as to how slight variations from one injection to another would affect P eff . While as much standardization as possible was attempted during each injection, the application of microneedles to deliver the contrast agent at defined depths with very precise volumes is a future enhancement that could reduce injection variability (27) .
Perspectives and Significance
Motivated by a significant need for minimally invasive methods for quantifying lymphatic pumping capacity in vivo, a pressure cuff system was designed and used in conjunction with an established NIR imaging system to measure differences in P eff upon dermal delivery of NO. The system utilized closed-loop feedback control with strong steady-state tracking ability and automation of the pressure application curve for repeatability and precision. Integrated image processing techniques allowed for quantification of lymphatic pumping capacity from NIR image sequences taken during cuff deflation. To show the functionality of such a system, it was demonstrated for the first time in vivo that dermally delivered NO causes a two-fold reduction in P eff . Additionally, we demonstrated that longer lymphatic vessel chain lengths have an increased potential to overcome adverse pressure gradients, something that has been theorized using lumped parameter modeling but was shown in vivo for the first time in this study. The ability to measure lymphatic pump function noninvasively has the potential to significantly enhance the ability to obtain actual functional data on lymphatic physiology in vivo. Implementation of the advances reported here holds strong potential for a diagnostic device to assist in the clinical early detection and diagnosis of lymphedema. 
